111130-13-3

Basic information

• Product Name: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt
• Synonyms: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt;CGP 35949;N-[3-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-chloro-6-methylphenyl]-1H-tetrazole-5-carboxamide
• CAS NO: 111130-13-3
• Molecular Formula: C23H26 Cl N5 O5 . Na
• Molecular Weight: 0
• Mol File: 111130-13-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 597.3°C at 760 mmHg
• Flash Point: 315°C
• Appearance: /
• Vapor Pressure: 4.11E-15mmHg at 25°C
• CAS DataBase Reference: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt(111130-13-3)
• EPA Substance Registry System: 1H-Tetrazole-5-carboxamide, N-(5-(3-(4-acetyl-3-hydroxy-2-propylphenox y)propoxy)-4-chloro-2-methylphenyl)-, monosodium salt(111130-13-3)

Safety Data

• Hazardous Substances Data: 111130-13-3(Hazardous Substances Data)

Usage

Molecular weight

461.01 g/mol

Structure

The compound contains a tetrazole ring (five-membered ring with four nitrogen atoms and one carbon atom) and a carboxamide group (-CONH~2~). It also includes a monosodium salt (Na^+^) of a derivative of a chloroand methyl-substituted phenyl group (C~6~H~4~Cl-), which is linked to a propylphenox y group (C~6~H~4~OCH~2~CH~2~CH~3~) and an acetyl group (CH~3~CO-).

Physical properties

The physical properties of this compound are not specified in the provided material.

Applications

The compound has potential applications in pharmaceuticals, but further research and evaluation are needed to fully understand its potential uses and implications.

Safety

The safety profile of this compound is not specified in the provided material.

Efficacy

The efficacy of this compound in drug development and formulation is not specified in the provided material. Further research is needed to determine its potential uses and benefits.

InChI:InChI=1/C23H26ClN5O5.Na/c1-4-6-16-19(8-7-15(14(3)30)21(16)31)33-9-5-10-34-20-12-18(13(2)11-17(20)24)25-23(32)22-26-28-29-27-22;/h7-8,11-12,25,31-32H,4-6,9-10H2,1-3H3;/q;+1/p-1